An investigation on behalf of investors, who currently hold shares of Civitas Solutions, Inc. (NYSE: CIVI), was announced concerning whether the takeover of Civitas Solutions, Inc. is unfair to NYSE: CIVI stockholders.

The investigation by a law firm concerns whether certain officers and directors of Civitas Solutions, Inc. breached their fiduciary duties owed to NYSE: CIVI investors in connection with the proposed acquisition.

Boston, MA based Civitas Solutions, Inc. provides home- and community-based health and human services to must-serve individuals with intellectual, developmental, behavioral, and/or medically complex challenges in the United States. On December 18, 2018, Civitas Solutions, Inc. (NYSE: CIVI) announced that it has entered into a merger agreement to be acquired by funds advised by Centerbridge Partners, L.P. (Centerbridge). Under the terms of the agreement, Centerbridge Partners, L.P. will acquire all outstanding shares of Civitas common stock for $17.75 in cash per share of Civitas common stock, resulting in an enterprise value of approximately $1.4 billion. The offer price represents a 27% premium to the 30-day volume-weighted average price as of December 18, 2018.

However, given that at least one analyst has set the high target price for NYSE: CIVI at $18 per share, the investigation concerns whether the offer is unfair to NYSE: CIVI stockholders. More specifically, the investigation concerns whether the Civitas Solutions Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Shares of Civitas Solutions, Inc. (NYSE: CIVI) closed on January 9, 2019, at $17.57 per share.